On November 6, 2024, Frank Corvino, former Director of HealthEquity Inc (HQY, Financial), sold 1,039 shares of the company. The transaction was documented in a recent SEC Filing. Following this sale, the insider now owns 3,784 shares of HealthEquity Inc.
HealthEquity Inc specializes in providing technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions. Their services include health savings accounts, health reimbursement arrangements, and other financial healthcare services.
Over the past year, Frank Corvino has sold a total of 9,991 shares and has not purchased any shares. This recent transaction is part of a broader trend observed within the company, where there have been 20 insider sells and no insider buys over the past year.
Shares of HealthEquity Inc were trading at $96.1 on the day of the sale, giving the company a market cap of approximately $8.629 billion. The price-earnings ratio of the company stands at 81.03, which is above the industry median of 22.56.
The stock's GF Value is estimated at $83.63, indicating that the stock is modestly overvalued with a price-to-GF-Value ratio of 1.15.
The GF Value is calculated considering historical trading multiples such as the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates from Morningstar analysts.
This insider sale might be of interest to investors tracking insider behaviors as an indicator of the company's future performance and valuation perspectives.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
